Source: International Congress 2018 – New modalities in asthma treatment
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Simpson (Newcastle, Australia), S. Sanchez-Ovando (Newcastle, Australia), H. Powell (Newcastle, Australia), K. Pabreja (Newcastle, Australia), I. Yang (Newcastle, Australia), J. Upham (Newcastle, Australia), P. Reynolds (Newcastle, Australia), S. Hodge (Newcastle, Australia), A. James (Newcastle, Australia), C. Jenkins (Newcastle, Australia), M. Peters (Newcastle, Australia), G. Marks (Newcastle, Australia), M. Baraket (Newcastle, Australia), P. Gibson (Newcastle, Australia). Increased sputum FKBP51 gene expression following Azithromycin add-on therapy in asthma. 1919

Member's Comments

No comment yet.

Related content which might interest you: Sputum IL-1ß is reduced with Azithromycin add-on therapy in patients with poorly controlled asthma Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 A sputum gene expression signature predicts oral corticosteroid response in asthma Source: Eur Respir J, 49 (6) 1700180; 10.1183/13993003.00180-2017 Year: 2017 Inhaled corticosteroids only decrease on the lymphocytes PGP expression and antileukotrienes mrp expression in asthmatic children after one month treatment Source: Annual Congress 2009 - Aspects of uncontrolled asthma Year: 2009 Modulation of sputum gene expression in COPD by fluticasone/salmeterol Source: Eur Respir J 2006; 28: Suppl. 50, 662s Year: 2006 Azithromycin treatment modifies airway and blood gene expression networks in neutrophilic COPD Source: ERJ Open Res, 4 (4) 00031-2018; 10.1183/23120541.00031-2018 Year: 2018 Immunocytochemistry evaluation of FKBP51 in induced sputum cells as a biomarker of glucocorticoid therapy in asthma Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Decreased levels of myeloperoxidase in induced sputum of COPD patients after oral glucocorticoids treatment Source: Eur Respir J 2002; 20: Suppl. 38, 404s Year: 2002 Antiviral biomarkers are upregulated in sputum cells following administration of inhaled interferon beta to COPD patients Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights Year: 2019 Differential expression of mRNA encoding for pro-inflammatory and angiogenic proteins in aspirin-tolerant and -intolerant asthma, following oral provocative aspirin challenge Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009 Restored HDAC-2 expression after corticosteroid and theophylline therapy in ex-smoker COPD patients Source: Annual Congress 2008 - Recent advances in the pathogenesis and treatment of asthma and COPD Year: 2008 Induced sputum in children with persistent asthma: the effect of inhaled corticosteroid treatment Source: Eur Respir J 2006; 28: Suppl. 50, 258s Year: 2006 Oral corticosteroid treatment reduces serum chitotriosidase activity in patients with COPD Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 Serum Amphiregulin expression in severe asthma patients treated with anti-IL-5 therapy Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020 Cytokine receptors expression in induced sputum in asthma and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 159s Year: 2001 Heat shock proteins and FKBP51 expression in sputum cells of COPD patients during formoterol/budesonide/theophylline therapy Source: Annual Congress 2010 - COPD and asthma: models and human studies Year: 2010 Failure of montelukast to reduce sputum eosinophilia in high-dose corticosteroid-dependent asthma Source: Eur Respir J 2005; 25: 41-46 Year: 2005 Azithromycin add-on therapy reduces airway inflammation and extracellular DNA: An AMAZES sub-study. Source: International Congress 2019 – Novel findings from asthma clinical trials Year: 2019 Does adherence to ICS/LABA therapy affect response to mepolizumab in the treatment of severe asthma? Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Long-term use of ICS influence TLR2 expression on induced sputum from severe COPD patients Source: Annual Congress 2012 - Lung injury and repair: reactive oxygen species and beyond Year: 2012 HBD-2 mutations are associated with childhood asthma and prophylactic hBD-2 application prevents asthma in mice Source: Virtual Congress 2021 – Paediatric lung disease: novel mechanisms, methods and translational studies Year: 2021